Annual Accounts Payable
$16.92 M
+$5.07 M+42.77%
December 31, 2023
Summary
- As of February 12, 2025, NAMS annual accounts payable is $16.92 million, with the most recent change of +$5.07 million (+42.77%) on December 31, 2023.
- During the last 3 years, NAMS annual accounts payable has risen by +$16.44 million (+3374.24%).
- NAMS annual accounts payable is now at all-time high.
Performance
NAMS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.04 M
+$1.76 M+33.44%
September 30, 2024
Summary
- As of February 12, 2025, NAMS quarterly accounts payable is $7.04 million, with the most recent change of +$1.76 million (+33.44%) on September 30, 2024.
- NAMS quarterly accounts payable is now -68.94% below its all-time high of $22.66 million, reached on June 30, 2023.
Performance
NAMS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NAMS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.8% | - |
| 3 y3 years | +3374.2% | -40.6% |
| 5 y5 years | +3374.2% | -40.6% |
NAMS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.3% | -68.9% | +33.4% |
| 5 y | 5-year | at high | +3374.2% | -68.9% | +33.4% |
| alltime | all time | at high | +3374.2% | -68.9% | +33.4% |
NewAmsterdam Pharma Company NV Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.04 M(+33.4%) |
| Jun 2024 | - | $5.28 M(-38.2%) |
| Mar 2024 | - | $8.54 M(-49.6%) |
| Dec 2023 | $16.92 M | $16.92 M(-25.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $22.66 M(+91.2%) |
| Dec 2022 | $11.85 M(+68.3%) | $11.85 M(-3.7%) |
| Jun 2022 | - | $12.31 M(+74.8%) |
| Dec 2021 | $7.04 M(+1345.6%) | $7.04 M |
| Dec 2020 | $487.10 K | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual accounts payable?
- What is the all time high annual accounts payable for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual accounts payable year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly accounts payable?
- What is the all time high quarterly accounts payable for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV annual accounts payable?
The current annual accounts payable of NAMS is $16.92 M
What is the all time high annual accounts payable for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual accounts payable is $16.92 M
What is NewAmsterdam Pharma Company NV annual accounts payable year-on-year change?
Over the past year, NAMS annual accounts payable has changed by +$5.07 M (+42.77%)
What is NewAmsterdam Pharma Company NV quarterly accounts payable?
The current quarterly accounts payable of NAMS is $7.04 M
What is the all time high quarterly accounts payable for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly accounts payable is $22.66 M